[pending] Azurion 7 M20. Fluoroscopic X-Ray System.
Pending LLM rewrite. Source: FDA_DEVICE Z-2134-2025.
- Product
- Azurion 7 M20. Fluoroscopic X-Ray System.
- Category
- Medical Device
- Distribution
- Distributed nationwide
State
19,787 recalls have nationwide distribution and so reach Idaho. 0 additional recalls listed Idaho specifically in their distribution scope.
Most US product recalls have nationwide distribution — the manufacturer ships into every state and the recall sweeps the same way. We include those in this listing because they affect Idaho consumers even though the source notice doesn’t name the state. State-specific recalls are usually for products with regional distribution (a regional dairy, a local store brand) or where the agency was able to narrow the affected shipments to specific destinations.
If you’re checking whether a recall affects your purchase, the recall detail page lists the exact production lot codes, UPCs, and best-by dates. Match those against your package — distribution scope is a starting filter, not the final answer.
Pending LLM rewrite. Source: FDA_DEVICE Z-2134-2025.
Pending LLM rewrite. Source: FDA_DEVICE Z-2151-2025.
Pending LLM rewrite. Source: FDA_DEVICE Z-2165-2025.
Pending LLM rewrite. Source: FDA_DEVICE Z-2163-2025.
Pending LLM rewrite. Source: FDA_DEVICE Z-2132-2025.
Pending LLM rewrite. Source: FDA_DEVICE Z-2133-2025.
Pending LLM rewrite. Source: FDA_DEVICE Z-2130-2025.
Pending LLM rewrite. Source: FDA_DEVICE Z-2136-2025.
Pending LLM rewrite. Source: FDA_DEVICE Z-2162-2025.
Pending LLM rewrite. Source: CPSC 25404.
Pending LLM rewrite. Source: CPSC 25405.
Pending LLM rewrite. Source: CPSC 25395.
Pending LLM rewrite. Source: CPSC 25397.
Pending LLM rewrite. Source: CPSC 25399.
Pending LLM rewrite. Source: CPSC 25398.
Pending LLM rewrite. Source: CPSC 25403.
Pending LLM rewrite. Source: CPSC 25408.
Pending LLM rewrite. Source: CPSC 25401.
Pending LLM rewrite. Source: CPSC 25394.
Pending LLM rewrite. Source: CPSC 25400.
Pending LLM rewrite. Source: CPSC 25396.
Pending LLM rewrite. Source: CPSC 25402.
Pending LLM rewrite. Source: FDA_DRUG D-0519-2025.
Pending LLM rewrite. Source: FDA_DRUG D-0534-2025.
Pending LLM rewrite. Source: FDA_DRUG D-0525-2025.